A nurse working in an urgent care clinic is collecting data from a client who takes montelukast. Which of the following is an expected therapeutic effect of this medication?

A. Montelukast is not associated with an increase in white blood cell count. B. Montelukast primarily acts as a leukotriene receptor antagonist, targeting inflammation in the airways, and does not affect peripheral vasodilation. C. Montelukast is not used for gastric acid neutralization; it is indicated for the treatment of respiratory conditions like asthma. D. Montelukast is known for its anti-inflammatory effects on the airways, reducing bronchial inflammation and improving symptoms in conditions like asthma.